- Home
- QVCGA vs RVPH Comparison
QVCGA vs RVPH Comparison
Compare QVCGA & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- RVPH
- Stock Information
- Founded
- QVCGA 1991
- RVPH 2006
- Country
- QVCGA United States
- RVPH United States
- Employees
- QVCGA N/A
- RVPH N/A
- Industry
- QVCGA
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- RVPH Health Care
- Exchange
- QVCGA NYSE
- RVPH Nasdaq
- Market Cap
- QVCGA 26.1M
- RVPH 32.8M
- IPO Year
- QVCGA N/A
- RVPH N/A
- Fundamental
- Price
- QVCGA $2.76
- RVPH $0.40
- Analyst Decision
- QVCGA
- RVPH Strong Buy
- Analyst Count
- QVCGA 0
- RVPH 5
- Target Price
- QVCGA N/A
- RVPH $9.00
- AVG Volume (30 Days)
- QVCGA 96.4K
- RVPH 3.8M
- Earning Date
- QVCGA 08-07-2025
- RVPH 08-13-2025
- Dividend Yield
- QVCGA N/A
- RVPH N/A
- EPS Growth
- QVCGA N/A
- RVPH N/A
- EPS
- QVCGA N/A
- RVPH N/A
- Revenue
- QVCGA $9,800,000,000.00
- RVPH N/A
- Revenue This Year
- QVCGA $2.89
- RVPH N/A
- Revenue Next Year
- QVCGA $0.45
- RVPH N/A
- P/E Ratio
- QVCGA N/A
- RVPH N/A
- Revenue Growth
- QVCGA N/A
- RVPH N/A
- 52 Week Low
- QVCGA $2.27
- RVPH $0.30
- 52 Week High
- QVCGA $39.66
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- RVPH 36.63
- Support Level
- QVCGA N/A
- RVPH $0.38
- Resistance Level
- QVCGA N/A
- RVPH $0.45
- Average True Range (ATR)
- QVCGA 0.00
- RVPH 0.04
- MACD
- QVCGA 0.00
- RVPH 0.01
- Stochastic Oscillator
- QVCGA 0.00
- RVPH 58.54
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.